Natco Pharma Limited — Updates, 10-10-2025: Press Release
10-10-2025 | 01:07 pm
10-10-2025 | 01:07 pm
NATCO Pharma's proposed acquisition of Adcock Ingram shares progressed as the Scheme Resolution passed with 98.66% votes. The ZAR 75.00 per share consideration is pending final conditions, leading to Adcock Ingram's delisting and marking a significant business development.
No comments yet. Be the first to comment!
